RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer
about
Mutations in the KIAA0196 gene at the SPG8 locus cause hereditary spastic paraplegiaThe ancient and evolving roles of cohesin in gene expression and DNA repairCleavage of Mcd1 by caspase-like protease Esp1 promotes apoptosis in budding yeastEvaluation of the 8q24 prostate cancer risk locus and MYC expression.A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapySister chromatid cohesion defects are associated with chromosome instability in Hodgkin lymphoma cells.Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers.Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis.The use of matrix coating assisted by an electric field (MCAEF) to enhance mass spectrometric imaging of human prostate cancer biomarkers.Deregulation of RAD21 and RUNX1 expression in endometrial cancer.Global transcriptional analysis of yeast cell death induced by mutation of sister chromatid cohesinCopy number variations in urine cell free DNA as biomarkers in advanced prostate cancer.Disruption of prostate epithelial differentiation pathways and prostate cancer development.Dynamic cohesin-mediated chromatin architecture controls epithelial-mesenchymal plasticity in cancer.Suppression of RAD21 Induces Senescence of MDA-MB-231 Human Breast Cancer Cells Through RB1 Pathway Activation Via c-Myc Downregulation.Cohesin Mutations in Myeloid Malignancies.Identification and functional analysis of differentially expressed genes in poorly differentiated hepatocellular carcinoma using RNA-seq.SMC1A knockdown induces growth suppression of human lung adenocarcinoma cells through G1/S cell cycle phase arrest and apoptosis pathways in vitro.MYC and Prostate CancerThe Arp2/3 Regulatory System and Its Deregulation in Cancer.
P2860
Q24680886-18E0D6CE-E6E6-4FC1-9EB7-3DE66E9A37D8Q27014855-3956DC62-64F8-443F-AD40-B010A749A494Q27939230-DD97DD8E-EEE1-4C52-BB56-9E0AF7F6BF7EQ30494853-B63A3E24-5037-44C2-9545-9C1F4ABD116AQ33375063-D46458A9-B709-4FCE-97A6-8EAA993ADC68Q34958631-C2CA1C70-C424-42E0-B4AB-EE51D33E550EQ35029537-7B18044B-5A97-495E-883A-98290FEA09B9Q35207795-5EDD9BBE-C72C-4960-9691-301E97C4E755Q35891644-363848EE-A741-4909-87D5-4254A3FA3EF1Q36423904-600755E4-E333-4687-AB98-18E4DAB5C52AQ36711633-B89075C4-9E53-4E03-B82E-AA0D9F9D188FQ37392579-3C8628BD-BBCA-4D37-A56D-3802305582A4Q38160495-32FE0F8D-D599-43D8-911A-0ED8FFCD6DFDQ38755283-78018CA2-07AD-4D42-ADC0-F5FDF6026C25Q38822527-7873A2A3-93CD-41CF-93A6-4FCFD0BB7306Q39381849-EBE6FBA6-2708-4B37-9E10-1026A1E2496EQ41056051-FCF46C86-8CA1-4123-9087-8B2B2494A479Q41876194-CDD61851-0964-4734-9C62-74E3D7E70D44Q42731671-B953B3FF-F91B-4504-AAFD-91332F1D2D25Q47322418-71A50FF0-0D5D-4474-93F1-3BD3BB2B28C0
P2860
RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer
@ast
RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer
@en
RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer
@nl
type
label
RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer
@ast
RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer
@en
RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer
@nl
prefLabel
RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer
@ast
RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer
@en
RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer
@nl
P2093
P2860
P3181
P356
P1476
RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer
@en
P2093
Kati P Porkka
Robert L Vessella
Teuvo L J Tammela
P2860
P3181
P356
10.1002/GCC.10289
P407
P577
2004-01-01T00:00:00Z